David A. Moore

12.5k total citations
30 papers, 737 citations indexed

About

David A. Moore is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David A. Moore has authored 30 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 11 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David A. Moore's work include Cancer Genomics and Diagnostics (11 papers), Cutaneous Melanoma Detection and Management (4 papers) and Lung Cancer Treatments and Mutations (4 papers). David A. Moore is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Cutaneous Melanoma Detection and Management (4 papers) and Lung Cancer Treatments and Mutations (4 papers). David A. Moore collaborates with scholars based in United Kingdom, United States and Sweden. David A. Moore's co-authors include Guido Sauter, Holger Moch, Russell Kerschmann, Michael J. Mihatsch, Fred Waldman, F Gudat, Karen Chew, Patrick Carroll, John Le Quesne and Gregory P. Sutton and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

David A. Moore

27 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Moore United Kingdom 16 337 266 190 141 123 30 737
Takafumi Koyama Japan 19 447 1.3× 293 1.1× 144 0.8× 80 0.6× 168 1.4× 87 871
Elena Poddubskaya Russia 16 478 1.4× 312 1.2× 236 1.2× 56 0.4× 269 2.2× 57 846
Andrew P. Sciallis United States 15 254 0.8× 225 0.8× 172 0.9× 96 0.7× 162 1.3× 39 770
Shane R. Stecklein United States 16 471 1.4× 374 1.4× 356 1.9× 91 0.6× 130 1.1× 52 934
Marlies S. Reimers Netherlands 16 536 1.6× 214 0.8× 268 1.4× 143 1.0× 144 1.2× 19 949
Natalie Y.L. Ngoi Singapore 17 506 1.5× 428 1.6× 146 0.8× 89 0.6× 121 1.0× 70 919
Tinghui Wu Taiwan 11 234 0.7× 106 0.4× 99 0.5× 61 0.4× 89 0.7× 28 589
Keisuke Tamari Japan 16 203 0.6× 159 0.6× 109 0.6× 76 0.5× 242 2.0× 72 676
Myriam Kossaï France 10 279 0.8× 277 1.0× 258 1.4× 68 0.5× 173 1.4× 36 768

Countries citing papers authored by David A. Moore

Since Specialization
Citations

This map shows the geographic impact of David A. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Moore more than expected).

Fields of papers citing papers by David A. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Moore. The network helps show where David A. Moore may publish in the future.

Co-authorship network of co-authors of David A. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Moore. A scholar is included among the top collaborators of David A. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Moore. David A. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powley, Ian, Cathy Richards, Hussein Uraiby, et al.. (2025). A histomorphological atlas of resected mesothelioma discovered by self-supervised learning from 3446 whole-slide images. Nature Communications. 16(1). 8891–8891. 1 indexed citations
2.
Moore, David A.. (2025). Signal-based Bayesian Seismic Monitoring. eScholarship (California Digital Library). 1293–1301.
3.
Coudray, Nicolas, Anna Yeaton, Xinyu Yang, et al.. (2024). Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides. Nature Communications. 15(1). 4596–4596. 24 indexed citations
4.
Puttick, Clare, Michelle Leung, Felipe Gálvez‐Cancino, et al.. (2024). MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution. Nature Genetics. 56(10). 2121–2131. 15 indexed citations
5.
Magness, Alastair, Emma Colliver, Katey S.S. Enfield, et al.. (2024). Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEX. Nature Communications. 15(1). 5135–5135. 2 indexed citations
6.
Jones, Lisa, David A. Moore, Y M Dailey, et al.. (2024). Socioeconomic Deprivation Correlates With Incomplete Radiotherapy Treatment in Head and Neck Cancer. Clinical Oncology. 37. 103649–103649. 1 indexed citations
7.
Coudray, Nicolas, Anna Yeaton, Xinyu Yang, et al.. (2023). P1.20-06 Mapping the Histopathological Landscape of Lung Adenocarcinoma using Self-Supervised Learning Artificial Intelligence. Journal of Thoracic Oncology. 18(11). S233–S233. 1 indexed citations
8.
Zhang, Hanyun, Khalid AbdulJabbar, David A. Moore, et al.. (2023). Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma. Cancer Research. 83(9). 1410–1425. 22 indexed citations
9.
Pearce, David R., Ayse U. Akarca, Roel P. H. De Maeyer, et al.. (2023). Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer. Frontiers in Oncology. 13. 1156743–1156743. 5 indexed citations
10.
Alexandrou, Constantia, Jennifer A. Higgins, William Boyle, et al.. (2018). Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes. Scientific Reports. 8(1). 12096–12096. 67 indexed citations
11.
Moore, David A., Callum Hall, Nicolai J. Birkbak, et al.. (2018). Genomic instability in mutant p53 cancer cells upon entotic engulfment. Nature Communications. 9(1). 3070–3070. 66 indexed citations
12.
Liao, Wenjing, Barry L. Sharp, John Pugh, et al.. (2017). Ex Vivo Explant Cultures of Non–Small Cell Lung Carcinoma Enable Evaluation of Primary Tumor Responses to Anticancer Therapy. Cancer Research. 77(8). 2029–2039. 68 indexed citations
13.
Moore, David A. & John Le Quesne. (2015). The molecular approach to diagnosis in lung cancer. British Journal of Hospital Medicine. 76(5). C74–C76. 1 indexed citations
14.
Moore, David A., et al.. (2015). Duplex Ratio Tests as Diagnostic Biomarkers in Malignant Melanoma. Journal of Molecular Diagnostics. 17(5). 616–622. 2 indexed citations
15.
Goldinger, Simone M., Jeannine D. Rinderknecht, Reinhard Dummer, et al.. (2015). A single‐dose mass balance and metabolite‐profiling study of vemurafenib in patients with metastatic melanoma. Pharmacology Research & Perspectives. 3(2). e00113–e00113. 22 indexed citations
16.
Moore, David A., et al.. (2013). Accurate Detection of Copy Number Changes in DNA Extracted from Formalin-Fixed, Paraffin-Embedded Melanoma Tissue Using Duplex Ratio Tests. Journal of Molecular Diagnostics. 15(5). 687–694. 8 indexed citations
17.
Moore, David A., James H. Pringle, & Gerald Saldanha. (2011). Prognostic tissue markers in melanoma. Histopathology. 60(5). 679–689. 8 indexed citations
18.
Sutton, Gregory P., John A. Blessing, Leslie R. DeMars, et al.. (1996). A Phase II Gynecologic Oncology Group Trial of Ifosfamide and Mesna in Advanced or Recurrent Adenocarcinoma of the Endometrium. Gynecologic Oncology. 63(1). 25–27. 31 indexed citations
19.
Geisler, John P., Katherine Y. Look, David A. Moore, & Gregory P. Sutton. (1995). Pelvic Exenteration for Malignant Melanomas of the Vagina or Urethra with over 3 mm of Invasion. Gynecologic Oncology. 59(3). 338–341. 41 indexed citations
20.
Sauter, Guido, Holger Moch, David A. Moore, et al.. (1993). Heterogeneity of erbB-2 gene amplification in bladder cancer.. PubMed. 53(10 Suppl). 2199–203. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026